Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

Oct 26, 2026 7:30 AM - Oct 27, 2026 4:00 PM

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 7, Track C: From Signal to Action -Managing Safety Risks in Self-Care Products Without Perfect Data

Session Chair(s)

Mei  Lam, BSN, RN

Mei Lam, BSN, RN

Associate Director Consumer Safety Regions Americas, Haleon, Canada

Liliana  Di Stabile, MD

Liliana Di Stabile, MD

Safety Physician, Knight Therapeutics Inc., Canada

This session explores how safety decisions are made for non-prescription and self-care products when data are incomplete or uncertain, integrating regulatory and industry perspectives. Drawing on real-world examples, Health Canada speakers will discuss how signals are identified, assessed, and translated into action, including balancing precaution with continuous monitoring, evidence thresholds, and regulatory judgment, while an industry speaker will share practical considerations and challenges in a model that was created for prescription products. The session will also highlight the growing use of non-traditional data sources and evolving regulatory tools to support post-market oversight. Attendees will gain practical insight into how uncertainty is navigated and managed across both regulators and industry in modern pharmacovigilance decision-making.

Learning Objective :
  • Explain how Health Canada identifies, assesses, and acts on safety signals for self-care products in the context of data uncertainty
  • Compare Health Canada’s regulatory approach with industry practices, including application of precaution, evidence thresholds, and lifecycle monitoring
  • Assess how Health Canada leverages emerging data sources and regulatory tools to strengthen post-market safety oversight and decision-making

Speaker(s)

Laurie  Chapman, PhD, MSc

Speaker

Laurie Chapman, PhD, MSc

Senior Scientific Evaluator, Health Canada, Canada

Safia  Hassan

Signal Management for Cannabis and Cannabis Products

Safia Hassan

Senior Regulatory Affairs Officer, Health Canada, Canada

Christopher  Gravel, PhD

Speaker

Christopher Gravel, PhD

Associate Professor, University of Ottawa (School of Epidemiology and Public Health), Canada

Representative Invited

Speaker

Representative Invited

MSc Epidemiology candidate / Research Assistant, University of Ottawa, Canada

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.